Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-11-02 | Dr. Gilad Aharon was appointed as a director of the Company in May 2020. The current members of the Compensation and Stock Option Committee are Roger G. Stoll (Chair), Elizabeth Czerepak and Dr. Gilad Aharon. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22